HSA
- Marketing authorisation holder: ASCENDIS PHARMA BONE
- Status: likely_approved
🇸🇬 Yorvipath in Singapore
Yorvipath (PALOPEGTERIPARATIDE) regulatory status in Singapore.
Marketing authorisation
Yorvipath in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Nephrology approved in Singapore
Frequently asked questions
Is Yorvipath approved in Singapore?
Yes. HSA has authorised it.
Who is the marketing authorisation holder for Yorvipath in Singapore?
ASCENDIS PHARMA BONE holds the Singaporean marketing authorisation.